Bacterial Protein Toxins 1971
DOI: 10.1016/b978-0-12-046502-6.50008-3
|View full text |Cite
|
Sign up to set email alerts
|

Tetanus Toxin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
12
0

Year Published

1975
1975
2014
2014

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(13 citation statements)
references
References 84 publications
1
12
0
Order By: Relevance
“…oedematiens type A &toxin. Because cholesterol inhibits these lysins in a manner identical to that for streptolysin 0 (van Heyningen, 1950), this finding provides additional evidence that cholesterol is involved. However, lysis by saponin which is also inhibited by free cholesterol (Ponder, 1945), was not affected by inhibitory factor (table The results in table I11 suggest that if cholesterol is involved it is not released from lipoprotein as free cholesterol molecules.…”
Section: Production Of Inhibitory Factorsupporting
confidence: 49%
“…oedematiens type A &toxin. Because cholesterol inhibits these lysins in a manner identical to that for streptolysin 0 (van Heyningen, 1950), this finding provides additional evidence that cholesterol is involved. However, lysis by saponin which is also inhibited by free cholesterol (Ponder, 1945), was not affected by inhibitory factor (table The results in table I11 suggest that if cholesterol is involved it is not released from lipoprotein as free cholesterol molecules.…”
Section: Production Of Inhibitory Factorsupporting
confidence: 49%
“…The toxigenic light chain (50 kDa) remains linked by a single disulfide bond to the binding domain of the targeting heavy chain (100 kDa). The principal targets of TeTx are both the central and peripheral nervous systems where inhibition of neurotransmitter release has been demonstrated (for review, see Mellanby, 1984;van Heyningen, 1986;Wellhöner, 1992;Niemann et al, 1994).…”
mentioning
confidence: 99%
“…There have been many studies on the production of human anti-tetanus MAbs (2,4,5,6,7,8,12,13,14,15,17,24,26,28,29) for two reasons. First, these MAbs would be useful clinically in place of horse antitoxin, which is not safe, or human polyclonal antibody, which is available in only limited amounts.…”
Section: Discussionmentioning
confidence: 99%